연구소에서 탄생한, 서울에서 만들어진.
CLINIC BORN.
SEOUL MADE.
CLINIC BORN.
SEOUL MADE.
From the home of skincare innovation comes a breakthrough discovery unlike any other.
Introducing the first modern molecule for unparalleled
anti-ageing performance.
In a series of independent clinical trials conducted by the Korean Skin Centre, REGENEXTM significantly outperformed Retinol in both wrinkle reduction and depigmentation.
[1] Clinical study on forehead wrinkles on 21 subjects by Dermapro Skin Research Center.
[1] Clinical study on forehead wrinkles on 21 subjects by Dermapro Skin Research Center.
UNPARALLELED
ANTI-AGEING PERFORMANCE.
Studied thoroughly, this powerful, patent-pending technology combines some of the most cutting edge active ingredients to regenerate skin cells.
Figure 1. Images of periorbital (around eyes) wrinkle following 8 weeks
consecutive application of the REGENEXTM Renewal Serum.
Figure 2. Changes in average overall wrinkle size following 8 consecutive weeks application of REGENEXTM and Retinol.
Clinical Results - In 8 Weeks:
(1) Glabellar (Between
Brows) Average Overall Wrinkle Size Reduction
(2) Nasolabial (Side of Nose to Mouth) Folds Average
Overall Wrinkle Size Reduction
(3) Upper Lip Average Overall Wrinkle Size
Reduction
(4) Periorbital (Around Eyes) Wrinkle Average Overall Wrinkle Size
Reduction
(5) Forehead Wrinkle Average Overall Wrinkle Size Reduction
Key Observation:
In 4 weeks: 7.2x better anti-ageing
results than Retinol for forehead wrinkles.
Study Overview:
Comparing the
efficacies of Modern Molecules REGENEXTM Renewal Serum and Retinol for
reducing the appearance of wrinkles.
Subjects:
21 male and female
subjects aged 49 to 60 years old with varying signs of facial ageing.
Methodology:
Randomised and placebo-controlled study with
1:1 ratio of participants applying on opposite sides of the face: on one
half of the face Modern Molecules REGENEXTM Renewal Serum against placebo
base cream with Retinol on the other half. Applied daily over 8 weeks.
Assessments conducted at 0, 2, 4, 6, and 8 weeks at 5 wrinkles sites
(glabellar, nasolabial folds, upper lip, periorbital, forehead) for overall
size, depth, width and maximum depth via 3D imaging.
Test Centre:
Dermapro Skin Research Center
Seoul,
Republic of Korea
June, 2024 - August, 2024
Figure 1. Images of skin colour in hyperpigmentation area following 8 weeks of application of REGENEXTM Renewal Serum.
Figure 2. Changes in hyperpigmentation following 8 consecutive weeks
application of REGENEXTM and Retinol.
Clinical Results - In 8 Weeks:
Statistical
analysis of skin colour in hyperpigmentation area parameter after 8 weeks
*The
L* value correlates with the level of pigmentation of the skin.
Key Observation:
In
2 weeks: 17x more reduction in hyperpigmentation than Retinol
Study Overview:
Comparing the efficacies of Modern Molecules REGENEXTM Renewal Serum and
Retinol for reducing the appearance of pigmentation and age spots.
Subjects:
21
male and female subjects aged 49 to 60 years old with hyper-pigmentation,
age spots, or other uneven tone.
Methodology:
Randomised and placebo-controlled study with 1:1 ratio of participants
applying on opposite sides of the face: on one half of the face Modern
Molecules REGENEXTM Renewal Serum against placebo base cream with Retinol on
the other half. Applied daily over 8 weeks.
Assessments conducted at 0, 2, 4, 6, and 8 weeks on skin colour in
hyperpigmentation measured using a Spectrophotometer.
Test Centre:
Dermapro Skin Research Center
Seoul, Republic of Korea
June, 2024 - August, 2024
Figure 1. Images of subject #1’s skin comparing signs of ageing
after 28 days of application of REGENEXTM Renewal Serum.
Figure 2. Images of subject #2’s skin comparing signs of ageing
after 28 days of application of REGENEXTM Renewal Serum.
Figure 1. Images of skin comparing per-orbital wrinkles after 8 weeks
of application of active ingredient.
Figure 2. Changes in skin tone and wrinkle size following 8 consecutive
weeks application of Peptide Complex in REGENEXTM.
Clinical Results - In 8 Weeks:
Study overview:
Examining
the anti-ageing performance of the branded Peptide Complex active in REGENEXTM
for reducing the appearance of all signs of ageing including wrinkles,
roughness and lack of elasticity and tone.
Subjects:
23 female participants
with 56 years mean age and varying signs of facial ageing.
Methodology:
Twice daily application of a cream containing
branded Peptide Complex active in REGENEXTM for 2 months on one half of the
face against placebo.
Assessments conducted before
and after 2 months treatment across ageing parameters including wrinkle
surface, density, depth, volume as well as skin roughness, elasticity and
tone.
Test Centre:
Sederma, France
December 2012
Figure 1. Changes in skin radiance and density following 2 consecutive weeks application of Exosomes in REGENEXTM.
Clinical Results:
In-vitro (test tube) study:
In-vivo (23 female) in 2 weeks:
Study overview:
Examining the anti-ageing performance of the branded Exosomes
active in REGENEXTM on skin cell regeneration key indicators such as
collagen production, wound healing, skin radiance, moisture, density and
elasticity.
Subjects:
In-vitro: Human
dermal fibroblast cells.
In-vivo: 23 female participants aged 20-60
years old for 2 weeks.
Test Centre:
ABio Materials, Korea
REGENEXTM is the first modern molecule for advanced anti-ageing that combines revolutionary Exosomes, Spicules and Peptides.
REGENEXTM is the first modern molecule for advanced anti-ageing that combines revolutionary Exosomes, Spicules and Peptides.
Scientific Director
Scientific Director at Dermapro Skin Research Center. Specialist in skin barrier.
Board-Certified Dermatologist
FACD, Fellow of the Australasian College of Dermatologists. Member of the American Academy of Aesthetic Medicine.
Cosmetic Scientist & Product Developer
2022 Top Voice in Beauty. Beauty Tech Insider Editor.
Aesthetic Doctor
Member of the Singapore Society of Aesthetic Medicine. Medical Director of VIDASKIN.